Masafumi Yamanaka - USS Officer VP
| USV Stock | EUR 8.65 0.05 0.58% |
Insider
Masafumi Yamanaka is Officer VP of USS Co
| Age | 69 |
| Phone | 81 52 689 1129 |
| Web | https://www.ussnet.co.jp |
USS Management Efficiency
The company has return on total asset (ROA) of 0.1276 % which means that it generated a profit of $0.1276 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1641 %, meaning that it generated $0.1641 on every $100 dollars invested by stockholders. USS's management efficiency ratios could be used to measure how well USS manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jennifer Reissman | Sabra Health Care | N/A | |
| Robert Esq | Quaker Chemical | 58 | |
| Eliza Gozar | Sabra Health Care | N/A | |
| Jeffery Lee | Sabra Health Care | N/A | |
| Andrew Tometich | Quaker Chemical | 56 | |
| Dhruwa Rai | Quaker Chemical | 54 | |
| Peter Nyland | Sabra Health Care | N/A | |
| Charles Cross | Sabra Health Care | 65 | |
| Tracey Dexter | Sabra Health Care | 49 | |
| Michael Sonego | Sabra Health Care | N/A | |
| Juliette Kleffel | Sabra Health Care | 52 | |
| Joseph Forlenza | Sabra Health Care | 61 | |
| Shane Hostetter | Quaker Chemical | 42 | |
| Harold Andrews | Sabra Health Care | 58 | |
| Darrin Smith | Sabra Health Care | N/A | |
| Lukas CFA | Sabra Health Care | N/A | |
| Jeffrey Schnell | Quaker Chemical | N/A | |
| Talya NevoHacohen | Sabra Health Care | 62 | |
| Daniel Chappell | Sabra Health Care | N/A | |
| Jeffrey Bray | Sabra Health Care | N/A | |
| Joseph Berquist | Quaker Chemical | 52 | |
Management Performance
| Return On Equity | 0.16 | |||
| Return On Asset | 0.13 |
USS Co Leadership Team
Elected by the shareholders, the USS's board of directors comprises two types of representatives: USS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of USS. The board's role is to monitor USS's management team and ensure that shareholders' interests are well served. USS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, USS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dai Seta, COO Pres | ||
| Masafumi Yamanaka, Officer VP | ||
| Yukiyasu Sugata, Exec Site | ||
| Hiroshi Kojima, Ex Officer | ||
| Hiromitsu Ikeda, Officer MD | ||
| Yukihiro Ando, Chairman CEO |
USS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is USS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.34 % | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 3.17 B | |||
| Shares Outstanding | 244.61 M | |||
| Shares Owned By Insiders | 18.39 % | |||
| Shares Owned By Institutions | 50.71 % | |||
| Price To Earning | 20.38 X | |||
| Price To Book | 2.91 X |
Currently Active Assets on Macroaxis
Other Information on Investing in USS Stock
USS financial ratios help investors to determine whether USS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in USS with respect to the benefits of owning USS security.